PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
70.23
Similar ESG score to CGTX's 66.89. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
70.45
Environmental score 1.1-1.2x CGTX's 65.49. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
73.58
Social score 1.1-1.2x CGTX's 64.94. Guy Spier would verify if superior social practices translate to better employee engagement and customer satisfaction.
66.65
Governance score 90-95% of CGTX's 70.23. Bill Ackman would demand clear governance improvement catalysts.